Recognizing the potential value of medical cannabis for treating some serious conditions, the Dayton Administration, lawmakers and advocates worked together to develop a compromise that allows suffering Minnesotans to use medical cannabis in a safe manner. A copy of the final legislation can be found online at Minnesota Session Laws CHAPTER 311--S.F.No. 2470.
As the program is implemented over the coming months, the following materials may help address common questions.
For more information or to ask questions not addressed here, please email requests to firstname.lastname@example.org or call 651-201-5598.
Medical Cannabis Program News
- Informal Draft for Comments (PDF: 139KB/13 pages) NEW
- Notice of Intent to Adopt Expedited Rules Without a Public Hearing NEW
- MDH receives 12 applications from parties seeking to become medical cannabis manufacturers
- Minnesota Health Department's Office of Medical Cannabis hires research manager
- Manufacturer Selection Process & Timeline Update
- Manufacturer Questions and Answers
- MDH receives 29 letters of intent
- Manufacturer Request for Applications Published
- Second Draft of Manufacturer Rules Published
- Additional Manufacturer Application Clarifications
- Manufacturer Application Clarifications
- Minnesota Department of Health hires director for Office of Medical Cannabis
Medical Cannabis Rulemaking
Implementation of the medical cannabis registry program will require significant rulemaking which will address different aspects of the program. You can find additional information on Medical Cannabis rulemaking online at Medical Cannabis Rulemaking.
Medical Cannabis Manufacturer Selection
The law requires that the Commissioner of Health register two medical cannabis manufacturers is required in law by December 1, 2014 with the expectation that they will begin providing medical cannabis to patients by July 1, 2015. In order to meet these goals the Office of Medical Cannabis is requesting applications from organizations interested in becoming a Minnesota medical cannabis manufacturer. You can find additional information about the manufacturer selection process online at Medical Cannabis Manufacturer Selection.
Task Force on Medical Cannabis Therapeutic Research
The Minnesota Legislature has created a 23-member task force to assess the impact of medical cannabis therapeutic research. The task force consists of legislators, state officials, consumers and patients, healthcare providers, law enforcement and substance use disorder treatment providers. Senator D. Scott Dibble and Representative Carly Melin co-chair the group. You can find additional information about the task force, including its members, online at the Legislative Coordinating Committee’s website: Task Force on Medical Cannabis Therapeutic Research.
No positions are currently available.
FAQ on Medical Cannabis in Minnesota
- What is Minnesota’s new policy regarding medical cannabis?
- When can Minnesotans start applying to join the medical cannabis patient registry?
- When will medical cannabis become available?
- Who will be able to use medical cannabis?
- Will people in bordering states be eligible to participate in the program?
- How will the process work?
- How much will patients pay to participate in the program?
- How can children or incapacitated patients get on the patient registry?
- On what grounds might a registry application be denied?
- Where will the state get the medical cannabis?
- How will the state select medical cannabis manufacturers?
- When will the state begin soliciting bids from entities seeking to become an approved medical cannabis manufacturer?
- Where will the medical cannabis distribution centers be located?
- How will the medical cannabis be distributed?
- In what forms will the medical cannabis be made available to patients on the registry?
- How will the state track the effectiveness and safety of medical cannabis?
- What are the obligations of patients and health care providers participating in the state’s medical cannabis program?